Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Noe

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|April 15, 1993
Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humansE K Rowinsky, D A Noe, D S Ettinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequences of taxol and cisplatin: a phase I and pharmacologic studyE K Rowinsky, M R Gilbert, W P McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumorsE K Rowinsky, D A Noe, D L Trump, et al.
Cancer Research|August 1, 1990
Phase I and pharmacokinetic study of brequinar sodium (NSC 368390)D A Noe, E K Rowinsky, H S Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenaseS D Baker, S P Khor, A A Adjei, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|April 15, 1993
Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humansE K Rowinsky, D A Noe, D S Ettinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequences of taxol and cisplatin: a phase I and pharmacologic studyE K Rowinsky, M R Gilbert, W P McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumorsE K Rowinsky, D A Noe, D L Trump, et al.
Cancer Research|August 1, 1990
Phase I and pharmacokinetic study of brequinar sodium (NSC 368390)D A Noe, E K Rowinsky, H S Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenaseS D Baker, S P Khor, A A Adjei, et al.
Pageof 5